NEWS | alsv | Page 15 of 15

Companies in the News

Sienna Biopharmaceuticals Announces $40 Million Series B Financing

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and...

Indigo’s Preliminary Commercial Data Demonstrate Significant Yield Gains for Growers with Plant Micr

Indigo™ Cotton demonstrated an average yield improvement of 11% in the target environment of West Texas Farmers experienced productivity...

Vir Biotechnology Launches To Cure, Treat, And Prevent Challenging Infectious Diseases Using Latest

-Former Biogen leader George Scangos will be CEO, with Vicki Sato as Chairman of the Board -Company to apply immune programming at...

Sienna Biopharmaceuticals Acquires Creabilis plc

Acquisition Adds Phase IIb Product, Clinical Candidates and Novel Discovery Platform to Sienna's Growing Pipeline WESTLAKE VILLAGE,...

BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BlackThorn Therapeutics, a clinical stage biopharmaceutical company discovering and...

Indigo Raises $100M in Series C Funding; Company Launches First Commercial Product for Water Efficie

BOSTON, MASS. — July 21, 2016 — Indigo, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announced...

Sienna Biopharmaceuticals Announces Second Closing of Series A Financing

STRONG INVESTOR DEMAND INCREASES TOTAL INVESTMENTS TO $46M Westlake Village, CA, July 12, 2016 – Sienna Biopharmaceuticals, Inc....

Millendo Therapeutics snags $62 Million Series B

Ann Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan...

eFFECTOR Therapeutics Raises $40 Million Series B Financing

SAN DIEGO, December 22, 2015 – eFFECTOR Therapeutics, a biopharmaceutical company developing translation regulators for the treatment of...